Latent tuberculosis screening before kidney transplantation in the South of Brazil

Detalhes bibliográficos
Autor(a) principal: Meinerz,Gisele
Data de Publicação: 2021
Outros Autores: Silva,Cynthia Keitel da, Dorsdt,Damaris Mikaela Balin, Adames,Julia Bertoni, Andrade,Julio Pasquali, Ventura,Pedro Enrico, Monteiro,Alexandre de Almeida, Pasqualotto,Alessandro Comarú, Garcia,Valter Duro, Keitel,Elizete
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Jornal Brasileiro de Nefrologia
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400520
Resumo: Abstract Background: Tuberculosis (TB) is a prevalent infection after kidney transplantation (KT) in high-burden countries. Latent tuberculosis infection (LTBI) screening includes previous TB history, chest radiograph findings, and tuberculin test (TST) and/or interferon-gamma release assays (IGRAs) results. We aimed to compare our routine LTBI screening of KT candidates and living donors (LD) with their IGRA results, and evaluate if this would improve isoniazid (INH) treatment referral. Methods: We evaluated adult KT candidates and LD with complete routine LTBI screening and QuantiFERON-TB® Gold In-Tube (QFT) testing. Blood samples were collected from April 4th, 2014 to October 31st, 2018, with follow-up until October 31st, 2019. Results: There were 116 KT recipients, with 30% QFT-positive results. Positive QFT was associated with past TB history (p=0.007), positive TST (p<0.0001), residual radiographic lesions (p=0.003), and diabetes (p=0.035). There were 25 LD, 40% had positive QFT. Positive QFT was associated with a positive TST (p=0.002). Positive QFT results increased INH referral in 80%. Post-transplant TB incidence was 2.6% in a median follow-up of 2 (1-33) months. No variables were associated with post-transplant TB. TB patients had inferior, although non-significant, 5-year graft survival (66.7% vs. 76.5%) (p = 0.402). Conclusion: In the present study, the association of QFT to our routine LTBI screening incremented INH treatment referral, but there was still a high incidence of post-transplant TB, possibly related to other forms of infection, such as new exposure and donor transmission.
id SBN-1_1df5a839b10d307b573991758fe3dd42
oai_identifier_str oai:scielo:S0101-28002021000400520
network_acronym_str SBN-1
network_name_str Jornal Brasileiro de Nefrologia
repository_id_str
spelling Latent tuberculosis screening before kidney transplantation in the South of BrazilKidney TransplantationTuberculosisLatent TuberculosisInterferon-gamma release assaysTuberculin TestAbstract Background: Tuberculosis (TB) is a prevalent infection after kidney transplantation (KT) in high-burden countries. Latent tuberculosis infection (LTBI) screening includes previous TB history, chest radiograph findings, and tuberculin test (TST) and/or interferon-gamma release assays (IGRAs) results. We aimed to compare our routine LTBI screening of KT candidates and living donors (LD) with their IGRA results, and evaluate if this would improve isoniazid (INH) treatment referral. Methods: We evaluated adult KT candidates and LD with complete routine LTBI screening and QuantiFERON-TB® Gold In-Tube (QFT) testing. Blood samples were collected from April 4th, 2014 to October 31st, 2018, with follow-up until October 31st, 2019. Results: There were 116 KT recipients, with 30% QFT-positive results. Positive QFT was associated with past TB history (p=0.007), positive TST (p<0.0001), residual radiographic lesions (p=0.003), and diabetes (p=0.035). There were 25 LD, 40% had positive QFT. Positive QFT was associated with a positive TST (p=0.002). Positive QFT results increased INH referral in 80%. Post-transplant TB incidence was 2.6% in a median follow-up of 2 (1-33) months. No variables were associated with post-transplant TB. TB patients had inferior, although non-significant, 5-year graft survival (66.7% vs. 76.5%) (p = 0.402). Conclusion: In the present study, the association of QFT to our routine LTBI screening incremented INH treatment referral, but there was still a high incidence of post-transplant TB, possibly related to other forms of infection, such as new exposure and donor transmission.Sociedade Brasileira de Nefrologia2021-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400520Brazilian Journal of Nephrology v.43 n.4 2021reponame:Jornal Brasileiro de Nefrologiainstname:Sociedade Brasileira de Nefrologia (SBN)instacron:SBN10.1590/2175-8239-jbn-2020-0189info:eu-repo/semantics/openAccessMeinerz,GiseleSilva,Cynthia Keitel daDorsdt,Damaris Mikaela BalinAdames,Julia BertoniAndrade,Julio PasqualiVentura,Pedro EnricoMonteiro,Alexandre de AlmeidaPasqualotto,Alessandro ComarúGarcia,Valter DuroKeitel,Elizeteeng2021-12-06T00:00:00Zoai:scielo:S0101-28002021000400520Revistahttp://www.bjn.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||jbn@sbn.org.br2175-82390101-2800opendoar:2021-12-06T00:00Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN)false
dc.title.none.fl_str_mv Latent tuberculosis screening before kidney transplantation in the South of Brazil
title Latent tuberculosis screening before kidney transplantation in the South of Brazil
spellingShingle Latent tuberculosis screening before kidney transplantation in the South of Brazil
Meinerz,Gisele
Kidney Transplantation
Tuberculosis
Latent Tuberculosis
Interferon-gamma release assays
Tuberculin Test
title_short Latent tuberculosis screening before kidney transplantation in the South of Brazil
title_full Latent tuberculosis screening before kidney transplantation in the South of Brazil
title_fullStr Latent tuberculosis screening before kidney transplantation in the South of Brazil
title_full_unstemmed Latent tuberculosis screening before kidney transplantation in the South of Brazil
title_sort Latent tuberculosis screening before kidney transplantation in the South of Brazil
author Meinerz,Gisele
author_facet Meinerz,Gisele
Silva,Cynthia Keitel da
Dorsdt,Damaris Mikaela Balin
Adames,Julia Bertoni
Andrade,Julio Pasquali
Ventura,Pedro Enrico
Monteiro,Alexandre de Almeida
Pasqualotto,Alessandro Comarú
Garcia,Valter Duro
Keitel,Elizete
author_role author
author2 Silva,Cynthia Keitel da
Dorsdt,Damaris Mikaela Balin
Adames,Julia Bertoni
Andrade,Julio Pasquali
Ventura,Pedro Enrico
Monteiro,Alexandre de Almeida
Pasqualotto,Alessandro Comarú
Garcia,Valter Duro
Keitel,Elizete
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Meinerz,Gisele
Silva,Cynthia Keitel da
Dorsdt,Damaris Mikaela Balin
Adames,Julia Bertoni
Andrade,Julio Pasquali
Ventura,Pedro Enrico
Monteiro,Alexandre de Almeida
Pasqualotto,Alessandro Comarú
Garcia,Valter Duro
Keitel,Elizete
dc.subject.por.fl_str_mv Kidney Transplantation
Tuberculosis
Latent Tuberculosis
Interferon-gamma release assays
Tuberculin Test
topic Kidney Transplantation
Tuberculosis
Latent Tuberculosis
Interferon-gamma release assays
Tuberculin Test
description Abstract Background: Tuberculosis (TB) is a prevalent infection after kidney transplantation (KT) in high-burden countries. Latent tuberculosis infection (LTBI) screening includes previous TB history, chest radiograph findings, and tuberculin test (TST) and/or interferon-gamma release assays (IGRAs) results. We aimed to compare our routine LTBI screening of KT candidates and living donors (LD) with their IGRA results, and evaluate if this would improve isoniazid (INH) treatment referral. Methods: We evaluated adult KT candidates and LD with complete routine LTBI screening and QuantiFERON-TB® Gold In-Tube (QFT) testing. Blood samples were collected from April 4th, 2014 to October 31st, 2018, with follow-up until October 31st, 2019. Results: There were 116 KT recipients, with 30% QFT-positive results. Positive QFT was associated with past TB history (p=0.007), positive TST (p<0.0001), residual radiographic lesions (p=0.003), and diabetes (p=0.035). There were 25 LD, 40% had positive QFT. Positive QFT was associated with a positive TST (p=0.002). Positive QFT results increased INH referral in 80%. Post-transplant TB incidence was 2.6% in a median follow-up of 2 (1-33) months. No variables were associated with post-transplant TB. TB patients had inferior, although non-significant, 5-year graft survival (66.7% vs. 76.5%) (p = 0.402). Conclusion: In the present study, the association of QFT to our routine LTBI screening incremented INH treatment referral, but there was still a high incidence of post-transplant TB, possibly related to other forms of infection, such as new exposure and donor transmission.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400520
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400520
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/2175-8239-jbn-2020-0189
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Nefrologia
publisher.none.fl_str_mv Sociedade Brasileira de Nefrologia
dc.source.none.fl_str_mv Brazilian Journal of Nephrology v.43 n.4 2021
reponame:Jornal Brasileiro de Nefrologia
instname:Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
instname_str Sociedade Brasileira de Nefrologia (SBN)
instacron_str SBN
institution SBN
reponame_str Jornal Brasileiro de Nefrologia
collection Jornal Brasileiro de Nefrologia
repository.name.fl_str_mv Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN)
repository.mail.fl_str_mv ||jbn@sbn.org.br
_version_ 1752122066997346304